Clinical Trials Logo
  1. Home
  2. Behavior Therapy
  3. NCT00084175
  4. Details
NCT00084175 Clinical Trial

HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs - 1

Behavior Therapy Clinical Trial

Official title:
HIV/STD Safer Sex Skills Groups for Men in Drug Treatment Programs

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00084175
Other study ID # NIDA-CTN-0018-1
Secondary ID
Status Completed
Phase Phase 3
First received June 8, 2004
Last updated January 11, 2017
Start date April 2004
Est. completion date September 2005

Study information
Verified date October 2016
Source National Institute on Drug Abuse (NIDA)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate a five-session Human Immunodeficiency Virus/Acquired Immune Deficiency Disease (HIV/AIDS) group therapy designed specifically for heterosexual men. This therapy is compared to standard HIV/AIDS education, which generally consists of a single session of HIV education.

Recruitment information / eligibility
Status Completed
Enrollment 630
Est. completion date September 2005
Est. primary completion date September 2005
Accepts healthy volunteers No
Gender Male
Age group 18 Years to 99 Years
Eligibility All adult males age 18 and above in drug abuse treatment at participating Community Treatment Providers will be invited to participate.

Study Design

Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Behavioral:
• Behavior Therapy

Locations
Country Name City State
United States LRADAC-Lexington-Richmond Alcohol & Drug Council Columbia South Carolina
United States Addiction Drug Services-Highpoint High Point North Carolina
United States Prestera Center for Mental Health Svcs. Huntington West Virginia
United States Hartford Dispensary New Britain Connecticut
United States CT Renaissance, Inc. Norwalk Connecticut
United States The Consortium Philadelphia Pennsylvania
United States Thomas Jefferson Intensive Sub. Abuse TP Philadelphia Pennsylvania
United States South Light Raleigh North Carolina
United States Matrix Institute on Addictions Rancho Cucamonga California
United States San Francisco General Hospital San Francisco California
United States Life Link Santa Fe New Mexico
United States Evergreen Treatment Services Seattle Washington
United States Staten Island University Hospital Staten Island New York
United States Comprehensive Addiction Services System Toledo Ohio

Sponsors (1)
Lead Sponsor Collaborator
University of Washington

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary AIDS risk behavior
See also
  Status Clinical Trial Phase
Completed NCT03443323 - Organizational Skills Training N/A
Completed NCT00102349 - HIV and HCV Intervention In Drug Treatment Settings - 1 Phase 3
Completed NCT02535598 - Therapy Labs: To Improve Adherence in Internet Based Psychotherapy N/A
Completed NCT00084188 - HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1 Phase 3
Completed NCT00158288 - The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 Phase 2
Completed NCT04420533 - Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms N/A
Recruiting NCT01365026 - PVS: Innovative Programs For Healthy Lifestyle Promotion in Primary Care: 'Prescribe Healthy Life' N/A
Completed NCT03001154 - Virtual Reality Exposure Therapy for Speech Anxiety Using Commercial Hardware and Software N/A
Not yet recruiting NCT06260020 - Development and Validation of a Comprehensive Module for Management of Sleep Disorders in ASD Children N/A
Completed NCT04235582 - Incentives to Decrease Opioid Use - Pilot N/A
Active, not recruiting NCT01318538 - Recovery Group for Women With Substance Use Disorders Phase 2